Cart
sales@molnova.com
Survodutide
Survodutide
Catalog No. M36653
Survodutide (BI 456906) is a dual agonist of glucagon and glucagon-like peptide 1 (GLP-1) receptors (GLP Receptor) that reduces body weight in HbA1c16 diabetes.
| Size | Price / USD | Stock | Quantity |
| 2MG | 161 | Get Quote |
|
| 5MG | 217 | Get Quote |
|
| 10MG | 330 | Get Quote |
|
| 25MG | 531 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameSurvodutide
-
Brief Description
-
Description
-
Storage
-
NoteResearch use only, not for human use.
-
Reference1. Tina Zimmermann, et al. BI 456906: Discovery and preclinical pharmacology of a novel GCGR/GLP-1R dual agonist with robust anti-obesity efficacy. Mol Metab. 2022 Dec:66:101633. ?
molnova catalog
related products
-
HAEGTFTSD
HAEGTFTSD is the first N-terminal 1-9 residues of GLP-1 peptide.The GLP-1 (7-36) amide is a product of the preproglucagon gene, which is secreted from intestinal L-cells, in response to the ingestion of food.
-
HAEGT
HAEGT is the first N-terminal 1-5 residues of GLP-1 peptide.
-
BETP
BETP is an agonist of GLP-1 receptor (EC50s: 0.66 and 0.755 μM for human and rat GLP-1 receptor).
